Evidence map›Paper›PMID 29138323›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Reply to Liu et al.: Yin and yang of PTEN regulation.

Per Johnsson, Nicholas Lister, Galina Shevchenko, James Walshe, Sandro F Ataide, Kevin V Morris

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Per JohnssonDepartment of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 65 Stockholm, Sweden.
Nicholas ListerThe University of New South Wales, Biotechnology and Biomedical Sciences, Sydney, NSW 2052, Australia.
Galina ShevchenkoCenter for Gene Therapy, City of Hope-Beckman Research Institute at the City of Hope, Duarte, CA 91010.
James WalsheDepartment of Chemistry, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Sandro F AtaideDepartment of Chemistry, School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
Kevin V MorrisCenter for Gene Therapy, City of Hope-Beckman Research Institute at the City of Hope, Duarte, CA 91010; kmorris@coh.org.

Funding

Targeted Delivery Vechicles for OligonucleotidesP01AI099783 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AKKINA, RAMESH · 2012 to 2016
$7.4M
Targeted inhibition of HIV-1 latencyR01AI111139 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2014 to 2018
$2.7M
NIAID NIH HHS P01 AI099783NIAID NIH HHS R01 AI111139
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29138323
PMCPMC5724290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.